-
Will Lilly's stock price rise by another 20%? BMO: Zepbound is expected to dominate the weight loss market this year
According to the latest report from BMO Capital Markets, US pharmaceutical giant Eli Lilly's GLP-1 drug Zepbound is expected to dominate the weight loss market in 2024, which will drive the company's ... -
Institution: The US stock market is still in the Goldilocks stage dominated by expectations of a "soft landing"
Overview of US stock market from early 2024 to present: Expectations of interest rate cuts pushed back, technology giants driving US stocks up 1.1. Resilience of economic data drives a rebound in US ... -
Heavy adjustment! The dominant position of large technology companies highlights the annual rebalancing of the Russell Index in the US stock market, which takes effect on Monday
With the end of the last trading day of this week, the US stock market closed smoothly in the first half of 2024, with all three major stock indices maintaining positive growth. Some institutions bel ... -
Is it difficult to drop 50 basis points directly? After the release of the CPI report, the expectation of the Federal Reserve cutting interest rates by 25 basis points in September has "prevailed"
After the release of the high-profile US CPI data in July, investors in the US bond market strengthened their bets on the US Federal Reserve officials to cut interest rates by 25 basis points in Sept ... -
A-shares surged on Friday! The reason has been found! Sora concept erupts, insurance stocks rise strongly
On Friday, Chinese assets surged sharply, with A-shares experiencing a "violent" surge starting from 10:30 am. As of the close, the Shanghai Composite Index rose 1.05% in volume, the Shenzhen Compone ...